,trastuzumab deruxtecan
astrazeneca,daiichi sankyo,allist
['destiny,breast,4', 'breast', 'bcsm', 'destiny-breast04', 'allist']
breaking #asco22 news: novel anti-body drug conjugate doubles progression-free survival in her2-low metastatic breast cancer. dr. modi breaks down some of the findings in the destiny-breast04 trial. #bcsm 
PhD CMPP, ex-geneticist/neuroscientist with a love of SpaceX and Formula 1. #Medcomms #Scicomms #parexel